WIN 2022 Program

INTEGRATING GENOMICS AND TRANSCRIPTOMICS TO RESHAPE PRECISION ONCOLOGY:
A WINNING STRATEGY

Tuesday March 15, 2022

SESSION 3 – DISRUPTIVE CONCEPTS AND METHODOLOGICAL INNOVATIONS IN NSCLC: MEET THE EXPERTS

Image Description

Keynote Lecture

Advances in Lung Cancer

Solange Peters

President ESMO, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Image Description

Early stage lung cancer: challenge and opportunity

Haiquan Chen

Fudan University, Shanghai, China

Image Description

Neoadjuvant and adjuvant strategies in NSCLC

Enriqueta Felip

Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Image Description

A focus on emerging paradigms in the treatment of early NSCLC

Jair Bar

Chaim Sheba Medical Center, Ramat Gan, Israel

Image Description

IO in combination: the SPRING trial tri-therapy approach

Benjamin Solomon

Avera Cancer Institute, Sioux Falls, USA

Image Description

New drugs for SCLC

Fiona Blackhall

The Christie and Manchester Cancer Research Centre, Manchester, UK

Coffee and Networking

SESSION 4 - WIN FIRST INTERNATIONAL MOLECULAR TUMOR BOARD: A STRATEGIC PLACE IN ADVANCING PRECISION ONCOLOGY

Image Description

First WIN International Molecular Tumor Board

Introduction

Patients' cases presentation by investigators. Discussion and treatment recommendation

Moderator

Razelle Kurzrock

WIN Consortium, Villejuif, France

Panel Discussion and Q&A from the audience

Lunch, poster viewing and networking

SESSION 5 – WHAT IS NEW IN BREAST, CRC, OVARY, HEAD & NECK, PROSTATE, KIDNEY, PEDIATRIC CANCERS?

Image Description

Opening Keynote Lecture

The BIG AURORA molecular screening program for metastatic breast cancer: first results

Martine Piccart

Institut Jules Bordet, Brussels, Belgium

Image Description

Keynote Lecture

Novel CRC insights based on combined genomic and
transcriptomic data at both bulk and single cell level, leading to new therapeutically relevant CRC classification

Sabine Tejpar

University of Leuven, Belgium

Image Description

Serial profiling in metastatic CRC; beyond the tip of the
iceberg

Gerald Batist

Segal Cancer Centre, Lady Davis Institute at the JGH, McGill University, Montréal, Canada

Image Description

Paradigm shift in treatment of ovarian cancers

Susan Galbraith

AstraZeneca, Gaithersburg, Maryland, USA

Image Description

Novel strategies in head & neck cancers

Christophe Le Tourneau

Institut Curie, Paris, France

Image Description

Expanding Precision Oncology across tumor types: advances in prostate cancer

Joaquín Mateo

Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

Image Description

Pediatric European Precision Cancer Medicine Program -
Facing cancer complexity

Birgit Geoerger

Gustave Roussy, Villejuif, France
ITCC

BEST TWO POSTERS' PRESENTATIONS AND AWARDS

Josep Tabernero, Vice-Chairman WIN Consortium, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Amir Onn, Head of the Standard Operating Procedures and repository Committee WIN Consortium
Chair, Institute of Pulmonary Medicine, Sheba Medical Center, Israel

CONCLUSIONS

Richard L. Schilsky, Chairman WIN Consortium

 

Download the WIN 2022 Program

Download the Program Here

WIN 2022 Symposium
c/o MCI UK Ltd
Durford Mill
Petersfield
GU31 5AZ

Tel: +44 (0) 1730 715223
General enquiries: winsymposium@mci-group.com
Sponsorship enquiries: winsymposium@mci-group.com
Abstract enquiries: winsympabstracts@mci-group.com
Registration enquiries: winsympreghot@mci-group.com

View Our Privacy Policy Here